Biomerica (BMRA) Capital Expenditures Growth (3y) (2013 - 2024)
Biomerica (BMRA) Capital Expenditures Growth (3y) (2013 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.84% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.15% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 7.57% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -6.22% |
| Nov 30, 2023 | -35.13% |
| Aug 31, 2023 | -19.05% |
| Feb 28, 2023 | -34.55% |
| Nov 30, 2022 | 79.47% |
| Aug 31, 2022 | 150.19% |
| May 31, 2022 | -4.63% |
| Feb 28, 2022 | -10.31% |
| Nov 30, 2021 | -4.48% |
| Aug 31, 2021 | -48.70% |
| May 31, 2021 | -19.63% |
| Feb 28, 2021 | 28.34% |
| Nov 30, 2020 | -12.63% |
| Aug 31, 2020 | 25.61% |
| May 31, 2020 | 185.82% |
| Feb 29, 2020 | -32.68% |
| May 31, 2019 | 9.35% |
| Feb 28, 2019 | -21.90% |
| Nov 30, 2018 | -12.79% |
| Aug 31, 2018 | 88.56% |